Recombinant urate oxidase
This page covers all Recombinant urate oxidase drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Uric acid (substrate); urate oxidase enzyme.
Targets
Uric acid (substrate); urate oxidase enzyme
Marketed (1)
- Rasburicase (SR29142) · Sanofi · Oncology
Rasburicase is a recombinant urate oxidase enzyme that catalyzes the conversion of uric acid to allantoin, a more soluble metabolite that is readily excreted.
Patent intelligence
- recombinant urate oxidase patent landscape — aggregated cliff calendar, attackable patents, originator estates